Sept 24 (Reuters) - Bavarian Nordic ( BVNKF ) has

received an additional order worth $63 million from the U.S.

Biomedical Advanced Research and Development Authority (BARDA)

to manufacture doses of the Jynneos mpox vaccine, it said on

Tuesday.

This contract will support the manufacturing of 1 million

freeze-dried vaccines to be delivered by 2026, the Danish

biotech company said.